Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

209 results about "Dose delivery" patented technology

Injection Device for Selective Fixed or Variable Dosing

A drug delivery device (1; 100; 200) comprising a housing (2; 102; 201, 202), a dose setting mechanism operable to set a dose to be delivered from a variable volume reservoir, and a dose delivery structure (60; 160; 260) activatable to expel a set dose. The dose setting mechanism comprises a dose indicating structure (40; 140; 240) for indicating a size of the set dose. The dose indicating structure (40; 140; 240) is coupled with the dose delivery structure (60; 160; 260) during expelling of the set dose and moved relative to the housing (2; 102; 201, 202) to a zero dose indicating position. The zero dose indicating position is a position which is fixed with respect to the housing (2; 102; 201, 202). The dose setting mechanism further comprises a dose setting structure (20; 120; 220) movable in a dose preparing direction relative to the housing (2; 102; 201, 202) to a dose prepared position to set a dose of a first size. The dose prepared position is a position along the dose preparing direction which is fixed with respect to the housing (2; 102; 201, 202). The dose setting structure (20; 120; 220) and the dose indicating structure (40; 140; 240) are coupled and configured to undergo first correlated displacements relative to the housing (2; 102; 201, 202) during movement of the dose indicating structure (40; 140; 240) to the zero dose indicating position and further coupled and configured to undergo second correlated displacements relative to the housing (2; 102; 201, 202) during movement of the dose setting structure (20; 20; 220) to the dose prepared position, where the first correlated displacements and the second correlated displacements are mutually reverse. Further, when the dose setting structure (20; 120; 220) is in the dose prepared position the dose indicating structure (40; 140; 240) is selectively displaceable relative to the housing (2; 102; 201, 202) while the dose setting structure (20; 120; 220) remains stationary in the dose preparing direction to allow adjustment of the dose of the first size and thereby setting of a dose of a second size.
Owner:NOVO NORDISK AS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products